HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND

INTRO: To ensure adequate coverage against numerous waves of different variants of concern, Thailand has proactively adopted heterologous primary and booster vaccination schedules. While studies have assessed homologous schedules in detail, the effectiveness of heterologous booster vaccine schedules...

Descripción completa

Detalles Bibliográficos
Autores principales: Chariyalertsak, S., Intawong, K., Chalom, K., Wonghirundecha, T., Kowatcharakul, W., Ayood, P., Thongprachum, A., Chotirosniramit, N., Noppakun, K., Teacharak, W., Khammawan, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186927/
http://dx.doi.org/10.1016/j.ijid.2023.04.333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186927/
http://dx.doi.org/10.1016/j.ijid.2023.04.333

Ejemplares similares